LeterMovir CAS 917389-32-3

Khoom Piav Qhia:

Khoom Lub Npe: LeterMovir CAS TSIS TAU: 917389-32-3

Lub ntsiab lus:

2-[(4S) -8-fluoro-2- [4- (3-methoxyphenyl) piperazin-1-yl] -3- [2-methoxy-5- (trifluoromethyl) phenyl] -4H-quinazolin-4-yl ] acetic acid;

AIC-246;

MK8828;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Khoom los yog kua

Kev Ntsuas: ≥99.00%

Ceev: 1.37 ± 0.1 g/cm3 (Kwv yees)

Kub Point: 706.5 ± 70.0 ℃ (Kwv yees)

PKa: 4.00 ± 0.10 (kwv yees)

Flash Point: 381.1 ± 35.7 ℃

Vapor Siab: 0.0 ± 2.4 mmHg ntawm 25 ℃

Index ntawm Refraction: 1.601

Letermovir yog cov tshuaj tiv thaiv kab mob tshiab ntawm CMV, uas yog lub hom phiaj kis tus kab mob sib kis thiab tseem ua haujlwm tiv thaiv kab mob tiv taus DNA polymerase inhibitors.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: letermovir cas 917389-32-3, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: Ropivacaine Hydrochloride CAS 132112-35-7
• Tom ntej: 2- [3-Methyl-4- (2,2,2-trifluoroethoxy) -2-pyridinyl] methylthio-1H-benzimidazole CAS 103577-40-8